BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 26636541)

  • 1. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
    Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
    Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rg3-induced EGFR/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4/LeY expression.
    Shan X; Aziz F; Tian LL; Wang XQ; Yan Q; Liu JW
    Int J Oncol; 2015 Apr; 46(4):1667-76. PubMed ID: 25672851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg3 suppresses FUT4 expression through inhibiting NF-κB/p65 signaling pathway to promote melanoma cell death.
    Shan X; Tian LL; Zhang YM; Wang XQ; Yan Q; Liu JW
    Int J Oncol; 2015 Aug; 47(2):701-9. PubMed ID: 26094873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness.
    Wang J; Tian L; Khan MN; Zhang L; Chen Q; Zhao Y; Yan Q; Fu L; Liu J
    Cancer Lett; 2018 Feb; 415():73-85. PubMed ID: 29199005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation.
    Wang A; Lu C; Ning Z; Gao W; Xie Y; Zhang N; Liang J; Abbasi FS; Yan Q; Liu J
    Oncotarget; 2017 Apr; 8(17):28247-28259. PubMed ID: 28423676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of HDAC3 by ginsenoside Rg3 inhibits epithelial-mesenchymal transition of cutaneous squamous cell carcinoma through c-Jun acetylation.
    Zhang L; Shan X; Chen Q; Xu D; Fan X; Yu M; Yan Q; Liu J
    J Cell Physiol; 2019 Dec; 234(12):22207-22219. PubMed ID: 31192452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rg3 Inhibits Migration and Invasion of Nasopharyngeal Carcinoma Cells and Suppresses Epithelial Mesenchymal Transition.
    Wang D; Wu C; Liu D; Zhang L; Long G; Hu G; Sun W
    Biomed Res Int; 2019; 2019():8407683. PubMed ID: 30915362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rg3 induces FUT4-mediated apoptosis in H. pylori CagA-treated gastric cancer cells by regulating SP1 and HSF1 expressions.
    Aziz F; Wang X; Liu J; Yan Q
    Toxicol In Vitro; 2016 Mar; 31():158-66. PubMed ID: 26427350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
    Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg3 Suppresses Epithelial-Mesenchymal Transition via Downregulating Notch-Hes1 Signaling in Colon Cancer Cells.
    Li X; Liu W; Geng C; Li T; Li Y; Guo Y; Wang C
    Am J Chin Med; 2021; 49(1):217-235. PubMed ID: 33371813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells.
    Qin Y; Zhang Q; Lee S; Zhong WL; Liu YR; Liu HJ; Zhao D; Chen S; Xiao T; Meng J; Jing XS; Wang J; Sun B; Dai TT; Yang C; Sun T; Zhou HG
    Oncotarget; 2015 Dec; 6(38):40667-79. PubMed ID: 26512779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg3 Reduces Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β1 by Inactivation of AKT in HMrSV5 Peritoneal Mesothelial Cells.
    Yan X; Zhang W; Kong F; Li Q; Shan W; Zhang C; Han T; Che Y; Zhang Y
    Med Sci Monit; 2019 Sep; 25():6972-6979. PubMed ID: 31527568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer.
    Shu J; Wang L; Han F; Chen Y; Wang S; Luo F
    Biomed Res Int; 2019; 2019():5937635. PubMed ID: 31886230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.
    Feng H; Lu JJ; Wang Y; Pei L; Chen X
    Cell Adh Migr; 2017 Sep; 11(5-6):464-475. PubMed ID: 28146373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside CK Inhibits TGF-
    Sun M; Zhuang X; Lv G; Lin Z; Huang X; Zhao J; Lin H; Wang Y
    Biomed Res Int; 2021; 2021():9140191. PubMed ID: 34934771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nicotine Induced Lung Cancer Cells Epithelial-mesenchymal Transition 
and Promote Its Vitro Invasion Potential].
    Hou Y; Li X; Pan Z; Zu L; Fan Y; You J; Wang Y; Wang M; Chen P; Shen W; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):169-76. PubMed ID: 27118643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.